180 related articles for article (PubMed ID: 19288173)
1. Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease.
Miklos S; Mueller G; Chang Y; Bouazzaoui A; Spacenko E; Schubert TEO; Grainger DJ; Holler E; Andreesen R; Hildebrandt GC
Int J Hematol; 2009 Apr; 89(3):383-397. PubMed ID: 19288173
[TBL] [Abstract][Full Text] [Related]
2. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
3. Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease.
Bouazzaoui A; Spacenko E; Mueller G; Miklos S; Huber E; Holler E; Andreesen R; Hildebrandt GC
Genes Immun; 2009 Dec; 10(8):687-701. PubMed ID: 19571824
[TBL] [Abstract][Full Text] [Related]
4. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
Cooke KR; Krenger W; Hill G; Martin TR; Kobzik L; Brewer J; Simmons R; Crawford JM; van den Brink MR; Ferrara JL
Blood; 1998 Oct; 92(7):2571-80. PubMed ID: 9746799
[TBL] [Abstract][Full Text] [Related]
5. The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.
Reckless J; Tatalick LM; Grainger DJ
Immunology; 2001 Jun; 103(2):244-54. PubMed ID: 11412312
[TBL] [Abstract][Full Text] [Related]
6. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
7. The broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina.
Fernando N; Natoli R; Valter K; Provis J; Rutar M
J Neuroinflammation; 2016 Feb; 13():47. PubMed ID: 26911327
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
9. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
[TBL] [Abstract][Full Text] [Related]
10. Broad spectrum chemokine inhibitors related to NR58-3.14.3.
Grainger DJ; Reckless J; Fox DJ
Mini Rev Med Chem; 2005 Sep; 5(9):825-32. PubMed ID: 16178724
[TBL] [Abstract][Full Text] [Related]
11. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
Martinu T; Gowdy KM; Nugent JL; Sun J; Kinnier CV; Nelson ME; Lyes MA; Kelly FL; Foster WM; Gunn MD; Palmer SM
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):810-21. PubMed ID: 24921973
[TBL] [Abstract][Full Text] [Related]
12. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.
Martinu T; Kinnier CV; Sun J; Kelly FL; Nelson ME; Garantziotis S; Foster WM; Palmer SM
PLoS One; 2014; 9(5):e97951. PubMed ID: 24844383
[TBL] [Abstract][Full Text] [Related]
14. Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.
Silva IA; Olkiewicz K; Askew D; Fisher JM; Chaudhary MN; Vannella KM; Deurloo DT; Choi SW; Pierce EM; Clouthier SG; Liu C; Cooke KR
Biol Blood Marrow Transplant; 2010 May; 16(5):598-611. PubMed ID: 20117226
[TBL] [Abstract][Full Text] [Related]
15. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chemokines prevents intraperitoneal adhesions in mice.
Berkkanoglu M; Zhang L; Ulukus M; Cakmak H; Kayisli UA; Kursun S; Arici A
Hum Reprod; 2005 Nov; 20(11):3047-52. PubMed ID: 16006464
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.
Wang H; Asavaroengchai W; Yeap BY; Wang MG; Wang S; Sykes M; Yang YG
Blood; 2009 Apr; 113(15):3612-9. PubMed ID: 19211507
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice.
Panoskaltsis-Mortari A; Hermanson JR; Taras E; Wangensteen OD; Serody JS; Blazar BR
Blood; 2003 May; 101(9):3714-21. PubMed ID: 12511416
[TBL] [Abstract][Full Text] [Related]
20. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
